^
Association details:
Biomarker:No biomarker
Cancer:Cutaneous Melanoma
Regimen:CVD (cisplatin + dacarbazine + vinblastine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
02/19/2021
Excerpt:
Melanoma: Cutaneous...Considerations for cytotoxic agents…Other agents include dacarbazine, paclitaxel, albumin-bound paclitaxel, or cisplatin/vinblastine/dacarbazine (CVD) (category 2B for CVD)